Radioterapia mais curta tem a mesma eficácia no glioblastoma A radioterapia é um dos esteios do tratamento do glioblastoma. Hoje... https://t.co/QUfkQNihB4
#newupdatesneuroonc #braintumours #neuroonc Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial) - https://t.co/ScL7Y444dV
RT @joostverhoeff: In 89 newly diagnosed GBM patients, 20x3Gy is comparable to standard 30x2Gy CRT in terms of survival outcome, with minim…
In 89 newly diagnosed GBM patients, 20x3Gy is comparable to standard 30x2Gy CRT in terms of survival outcome, with minimal toxicity. Dose escalation and 2 weeks reduction in overall treatment time is an advantage. #radonc https://t.co/3nVy5ZtTCK
Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized t... - PubMed - NCBI https://t.co/7V8m6YXTuj #newupdatesneuroonc
RT @radonconeuro: #newupdatesneuroonc #braintumours #neuroonc Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant…
RT @radonconeuro: #newupdatesneuroonc #braintumours #neuroonc Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant…
#newupdatesneuroonc #braintumours #neuroonc Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial). - https://t.co/5zFIXgizor